Gen Book 2018
Genomma Lab Internacional S.A.B. de C.V one of the leading pharmaceutical and personal care products companies in Mexico with an increasing international presence, develops, sells and markets a broad range of Premium brandend products, many of which are leaders in their categories.
Mr. Jorge Brake, Chief Executive Officer, commented: We achieved a solid first quarter 2021 despite the significant impacts from COVID-19. Importantly, Genomma’s results remain aligned with our strategic goals and objectives to drive long-term sustainable growth while maintaining robust levels of profitability and liquidity. We continue to identify exciting opportunities to capitalize fully on our Company’s incredible potential, particularly related to technological and product innovation, while leveraging accelerating consumer trends including the sustained shift to wellness and self-care through trusted brands with increased digital engagement- which we are confident will continue to persist even beyond the pandemic.” He added: I’d again like to recognize Genomma’s employees who have enabled us to overcome multiple challenges, as the collective power of our people drives our momentum and success. Our team has moved swiftly and decisively to serve our customers and communities at this critical time. 2021 is our team’s year, therefore, we remain aligned with the Company’s mission: to empower people to have excellent health and well-being.”
Chief Executive Officer
April 28, 2021
To improve and preserve the health and well-being of our customers through innovative, safe and effective products, providing development opportunities to our collaborators, profitability to our shareholders and positively impacting our community and environment.
To be the leading company in the pharmaceutical and personal care products markets in which we are active; and to be recognized for our positive impact on the health and welfare of people, communities and the environment.
of net sales
of net sales
of net sales
Points of sale+450,000
Sales 2020 (MXN mm)$13,867
(OTC: 52%2, PC: 48%3)
EBITDA (MXN mm)$2,932
1As a percentage of FY 2020 consolidated sales, 2Over The Counter, 3Personal Care
Genomma Lab is committed to enriching the well-being of our society by improving life quality of the consumers of our products via the investigation and analysis of the optimal ingredients for the development and commercialization of our personal care and OTC pharmaceutical products, and in so doing, generating the maximum levels of profitability possible for our investors.
Rodrigo Herrera Aspra
Founder and Chairman of the Board
Genomma Lab, a Mexican company that has changed the business model in the pharmaceutical industry, presents events, news and financial statements in our website for investors.
Corporate Social Responsibility
Our People. Responsible Actions
The generation of value is the result of the commitment, talent and integrity of our team.
Our Communities. Responsible Actions
We redouble efforts in social welfare programs, both internally and externally.
The quality of our products is what most interests us and the satisfaction of our customers is what pleases us the most.